CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 146 filers reported holding CEMPRA INC in Q2 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $107,000 | -25.2% | 32,868 | +5.4% | 0.00% | 0.0% |
Q2 2017 | $143,000 | +15.3% | 31,182 | -5.8% | 0.00% | 0.0% |
Q1 2017 | $124,000 | +6.0% | 33,103 | -20.8% | 0.00% | 0.0% |
Q4 2016 | $117,000 | -87.2% | 41,776 | +10.3% | 0.00% | -92.3% |
Q3 2016 | $916,000 | +35.7% | 37,858 | -7.5% | 0.01% | +44.4% |
Q2 2016 | $675,000 | -3.6% | 40,947 | +2.5% | 0.01% | -10.0% |
Q1 2016 | $700,000 | -43.8% | 39,961 | -0.1% | 0.01% | -33.3% |
Q4 2015 | $1,245,000 | +22.5% | 39,993 | +9.6% | 0.02% | +7.1% |
Q3 2015 | $1,016,000 | -23.9% | 36,503 | -6.0% | 0.01% | -22.2% |
Q2 2015 | $1,335,000 | -4.8% | 38,843 | -4.9% | 0.02% | +5.9% |
Q1 2015 | $1,402,000 | +105.3% | 40,863 | +40.7% | 0.02% | +112.5% |
Q4 2014 | $683,000 | +138.0% | 29,033 | +10.8% | 0.01% | +100.0% |
Q3 2014 | $287,000 | -14.6% | 26,208 | -16.3% | 0.00% | 0.0% |
Q2 2014 | $336,000 | -36.0% | 31,297 | -31.1% | 0.00% | -42.9% |
Q1 2014 | $525,000 | +163.8% | 45,422 | +183.4% | 0.01% | +133.3% |
Q4 2013 | $199,000 | +38.2% | 16,029 | +28.4% | 0.00% | 0.0% |
Q3 2013 | $144,000 | – | 12,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |